• CN1 Cost-Effectiveness of Trastuzumab in the Adjuvant Treatment of Early Breast Cancer in Six Latin American Countries

    Nov 1, 2011, 00:00

  • PIN106 HIV Screening Programme in Community Pharmacies of the Basque Country

    Nov 1, 2011, 00:00

  • PCV10 Anti-Glycemic Medication Treatment Patterns Among Type II Diabetes Mellitus Patients Initiating Lipid-Altering Regimens

    Nov 1, 2011, 00:00

  • PSY16 Cost and Quality of Life Benefits of Faster Bleed Resolution with an Rfviia Analogue- a Mathematical Simulation Study for the German Population

    Nov 1, 2011, 00:00

  • PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil- Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticos

    Nov 1, 2011, 00:00

  • PCV9 Optimal Treatment Shortfalls and Worse 12-Month Outcomes for Diabetic Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention in Contemporary Practi Data from the Multinational, Prospective, Antiplatelet Treatment Out ...

    Nov 1, 2011, 00:00

  • PCV89 Cost-Effectiveness Analysis of Rosuvastatin Versus Generic Atorvastatin in Patients at High Cardiovascular Risk in Spain

    Nov 1, 2011, 00:00

  • CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion Medica

    Nov 1, 2011, 00:00

  • PMH27 An Economic Analysis of the Impact of Crime and Hospitalisation Associated with Different Interventions for Opioid Abuse in the United Kingdom

    Nov 1, 2011, 00:00

  • PRM58 Methodological Reviews of Economic Evaluations in Health Care- Are They Useful?

    Nov 1, 2011, 00:00

  • PCV93 the Polypill in the Primary Prevention of Cardiovascular Disease- Cost-Effectiveness in the Dutch Population

    Nov 1, 2011, 00:00

  • PCV116 The Impact of High Risk of Stroke Patients Diagnosed with atrial Fibrillation on Health-Related Quality of Life, and Health Care Use in 5EU

    Nov 1, 2011, 00:00

  • PMH84 The Cornell-Brown Scale for Quality of Life in Dementia- Spanish Adaptation and Validation

    Nov 1, 2011, 00:00

  • PDB37 Injection of Long-Acting Somatostatin Analogs- A Cost Consequence Analysis for Three European Countries

    Nov 1, 2011, 00:00

  • PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients- An Analysis with the RAMQ Database

    Nov 1, 2011, 00:00

  • PDB53 Diabetes Medication Adherence and Glycemic Control in Penang, Malaysia

    Nov 1, 2011, 00:00

  • PSY11 Budget Impact Model of Hemophilia a Treatment in Turkey- a Payer'S Perspective

    Nov 1, 2011, 00:00

  • PCN104 Cost Minimization Analysis (CMA) of Capecitabine/Cisplatin (XP) vs. 5-Fu/Cisplatin (FP) Regimens in Advanced Gastric Cancer (AGC) Treatment in the Romanian Setting

    Nov 1, 2011, 00:00

  • PHP23 La Aceptacion De Las Vacunas En Los programas Nacionales De inmunizacion En Latina America- Un Estudio Comparativo

    Nov 1, 2011, 00:00

  • HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in Belize

    Nov 1, 2011, 00:00

  • PND52 Responsiveness of the Multiple Sclerosis International Quality of Life and Short Form-36 Questionnaires to Expanded Disability Status Scale Score Changes in Subjects with Multiple Sclerosis- Final 24-Month Results From An Internationa ...

    Nov 1, 2011, 00:00

  • PCV43 Budget Impact of the Implementation of a Treatment Protocol for Pulmonary Arterial Hypertension in A Referral Hospital

    Nov 1, 2011, 00:00

  • PMD81 Decision Analytic Models Used in Estimating the Cost-Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents

    Nov 1, 2011, 00:00

  • PMH75 Physician Differences between Italy and Germany- The Treatment of Opioid Dependence with Substitution Therapy

    Nov 1, 2011, 00:00

  • PIN93 Assessment of Knowledge and Awareness of Hepatitis B Among General Public in Pakistan

    Nov 1, 2011, 00:00

  • PGI5 Irritable Bowel Syndrome with Constipation (IBS-C)- A European-Focused Systematic Literature Review of Disease Burden

    Nov 1, 2011, 00:00

  • PMS75 Explanatory Factors for the Rheumatoid Arthritis Patients' Access to Biological Agents in 15 European Countries

    Nov 1, 2011, 00:00

  • PSY32 Modeling Cost-Effectiveness of Drug Treatments for Severe Chronic Non-Cancer Pain in Portugal

    Nov 1, 2011, 00:00

  • PMD70 A Review of the Geographic Variations in the Implant Rate of Transcatheter Aortic Valves in 14 European Countries

    Nov 1, 2011, 00:00

  • PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources

    Nov 1, 2011, 00:00

  • MA2 Mapping Fact-P to Country Specific Patient Health Status Measured by EQ-5D in Metastatic Castrate Resistant Prostate Cancer Patients

    Nov 1, 2011, 00:00

  • PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) Population

    Nov 1, 2011, 00:00

  • PCN9 Economic Evaluation of Panitumumab vs Cetuximab in Patients with Colorectal Carcinoma (CRCM) with Non-Mutated (WILD-TYPE) Kras After Failure of Chemotherapy Regimens in Mexico

    Nov 1, 2011, 00:00

  • PDB22 ‘Real-World' Clinical Outcomes of Exenatide Bid Compared to Insulin Glargine in Patients with Type 2 Diabetes

    Nov 1, 2011, 00:00

  • PRM47 Review of Clinician and Observer Reported Outcomes Measures Translation Methodologies

    Nov 1, 2011, 00:00

  • PR2 The Beauty of Mapping- Need the Mean Health-Related Quality of Life Score for a Group of Hip Patients and Don't Have EQ-5D? Just Use the Oxford Hip Score!

    Nov 1, 2011, 00:00

  • PMS8 Prevalence of Clinical Risk Factors for Fractures in the Canadian Multicentre Osteoporosis Study

    Nov 1, 2011, 00:00

  • PCN20 Systematic Review of Skeletal Related Events in Breast Cancer

    Nov 1, 2011, 00:00

  • PMD56 A Systematic Literature review on the Clinical and Economic outcomes attributable to the Use of Hemostatic Matrix during Tonsillectomy and Adenoidectomy

    Nov 1, 2011, 00:00

  • PHP121 The Role of Molecular Tests in Shaping Comparative Effectiveness Review (CER)

    Nov 1, 2011, 00:00

  • PIH34 Patient Reported Reasons for Medication Nonadheren A Survey

    Nov 1, 2011, 00:00

  • PMH5 Analisis De Costo Efectividad Del Manejo Farmacologico De La Esquizofrenia Recurrente En Peru Ajustado Por La Adherencia Ai Tratamiento

    Nov 1, 2011, 00:00

  • PHP44 Characteristics of Patients Treated for Fibromyalgia in Puerto Rico and the United States- Baseline Findings of the Reflections Study (Real World Examination of Fibromyalgia- Longitudinal Evaluation of Costs and Treatments)

    Nov 1, 2011, 00:00

  • PRM5 Incorporating Equity Into Developing and Implementing Evidence-Based Clinical Practice Guidelines

    Nov 1, 2011, 00:00

  • PHP82 A Study Explorating the General Public Perceptions Towards Medicines

    Nov 1, 2011, 00:00

  • PND7 Disability Progression in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) Who Experience Disease Activity Despite Previous Disease Modifying Therapy

    Nov 1, 2011, 00:00

  • PHP49 The Pharmacist'S Perception of the Splitting Extended Release and Enteric-Coated Formulation Drugs

    Nov 1, 2011, 00:00

  • PHP31 Analisis Costo Efectividad Sectorial De 45 Intervenciones Sanitarias En Chile

    Nov 1, 2011, 00:00

  • PIN80 Cost-Effectiveness of Vaccinating Children Aged 2-17 Years with Intranasal Live Attenuated Influenza Vaccine (LAIV) in Germany

    Nov 1, 2011, 00:00

  • PND43 Validation of the Self Assessment of Treatment (SAT) Questionnaire

    Nov 1, 2011, 00:00

  • QA4 Cost-Utility of Sacral Neuromodulation Versus Augmentation Cystoplasty for Treatment of Refractory Urge Incontinence in México

    Nov 1, 2011, 00:00

  • PSU23 Rehabilitation Needs and Predictive Factors of Health-Related Quality-of-Life in Breast Cancer Patients During Two Years After Surgery - A Multicenter Prospective Study

    Nov 1, 2011, 00:00

  • PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special Populations

    Nov 1, 2011, 00:00

  • CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL- A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials

    Nov 1, 2011, 00:00

  • PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer Therapy

    Nov 1, 2011, 00:00

  • PSY38 Estimating Healthy-Time Equivalents for Migraine Treatment Outcomes from Conjoint Analysis Measures of Patient Preferences

    Nov 1, 2011, 00:00

  • PIN17 Modelling Budget Impact (BI) of Vaccinating At-Risk Adults and the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Germany

    Nov 1, 2011, 00:00

  • PHP73 Government Reduces Public Pharmaceutical Expenditure in Hungary- Rational Decisions in Challenging Economic times?

    Nov 1, 2011, 00:00

  • PIH3 Resource Use And Associated Costs For The Treatment Of Heavy Menstrual Bleeding With Levonorgestrel Releasing Intrauterine System (LNG-IUS) Versus Hysterectomy- The Brazilian Public Healthcare System (SUS) Perspective

    Nov 1, 2011, 00:00

  • PGI10 Analysis of Originator Versus Generic Prescribing of Proton Pump Inhibitors

    Nov 1, 2011, 00:00

  • PCV69 Economic Evaluation of Primary Prevention of Cardiovascular Diseases in Mild Hypertension- A Scenario Analysis for the Netherlands

    Nov 1, 2011, 00:00

  • PCV109 Measuring Health Utility in Thai Stroke Patients

    Nov 1, 2011, 00:00

  • PHP108 Public Health and Prevention in Europe- Is it Cost-Effective?

    Nov 1, 2011, 00:00

  • PIN6 Clinical Outcomes Analysis Comparing Entecavir with Lamivudine Monotherapy and Lamivudine with “Tenofovir Add-on as Needed” Approach in the Treatment of Chronic Hepatitis B Infection in Turkey

    Nov 1, 2011, 00:00

  • PRM35 Agreement Between Patients' Self-Report and Physicians' Prescriptions on Drugs and Vaccine Exposure- The International PGRX Database Experience

    Nov 1, 2011, 00:00

  • PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in Australia

    Nov 1, 2011, 00:00

  • PRS7 Efficacy and Safety of Sildenafil Above 60 mg Daily in Pulmonary Arterial Hypertension Treatment - a Systematic Literature Review

    Nov 1, 2011, 00:00

  • PCN82 Cost-Effectiveness Analysis of Trastuzumab + Docetaxel Versus Docetaxel Alone in the Treatment of HER2+ Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PHP40 Perception Study of Undergraduates Towards Medicines – A Survey

    Nov 1, 2011, 00:00

  • PDB33 Cost of Diabetes Management to Cocoa Clinics in Ghana

    Nov 1, 2011, 00:00

  • PHP140 “Troica” Health Care Economics in Greece

    Nov 1, 2011, 00:00

  • PCV8 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System Persp ...

    Nov 1, 2011, 00:00

  • PCV67 Health-Economic Impact of the Hungarian Salt Intake Reduction Program

    Nov 1, 2011, 00:00

  • PCN43 Cost of HPV Associated Diseases in Saint-Petersburg

    Nov 1, 2011, 00:00

  • PSS9 The Burden of Age-related Macular Degeneration in the Netherlands

    Nov 1, 2011, 00:00

  • PND21 Cost of Alzheimer'S Disease in Romania

    Nov 1, 2011, 00:00

  • PCV50 Hospital Costs Associated with Atrial Fibrillation in Canada

    Nov 1, 2011, 00:00

  • PDB27 Projected Cost-Effectiveness of Exenatide Once Weekly Versus Exenatide Bid for the Treatment of Type 2 Diabetes in the UK

    Nov 1, 2011, 00:00

  • MO3 A Methodological Framework for Developing Models of Whole Disease Areas to Inform Resource Allocation Decisions

    Nov 1, 2011, 00:00

  • PCV136 Factors Associated with Failing to Achieve Low Density Lipoprotein Cholesterol Goal with Existing Statin Therapy- A Chart Extraction-Based Approach

    Nov 1, 2011, 00:00

  • PDB4 Gastos Com Medicamentos E Características De indivÍduos Com HipertensÃo E Diabetes Mellitus, Em MunicÍpios Da rede FarmÁcia De Minas - Minas Gerais, Brasil

    Nov 1, 2011, 00:00

  • PMH13 Differences Between Patients Undergoing Augmentation or Switching of Antipsychotic Medications During Treatment of Schizophrenia

    Nov 1, 2011, 00:00

  • PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech Republic

    Nov 1, 2011, 00:00

  • PCN154 Discussing the Introduction of National Screening Programs in Gree A Delphi Study

    Nov 1, 2011, 00:00

  • PMD61 The Effects of Subjective Insomnia Pattern on the quality of Life of the Climacteric Women in Taiwan

    Nov 1, 2011, 00:00

  • PSS13 Economic Burden of Psoriasis and Diabetes in Patients With Psoriasis in the United States

    Nov 1, 2011, 00:00

  • PIN64 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in Guatemala

    Nov 1, 2011, 00:00

  • PDB3 Hypoglycaemia-Related Emergency Department Visits and Hypoglycaemia-Related Hospitalizations Among News Users of Antidiabetes Treatments

    Nov 1, 2011, 00:00

  • PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United States

    Nov 1, 2011, 00:00

  • PMS1 Tumor Necrosis Factor Alpha Inhibitors for the Treatment of Active Ankylosing Spondylitis

    Nov 1, 2011, 00:00

  • PCN156 A Survey Examining Treatment Patterns of Melanoma in Australia

    Nov 1, 2011, 00:00

  • PMD8 Systematic Review of the Impact Different Metal Femoral Stems (MFSS) Have on Patient outcomes in total Hip replacement (THR) Due to Osteoarthritis (OA)

    Nov 1, 2011, 00:00

  • PR4 Calidad De Vida Y Victimizacion En Adolescentes Estudiantes De MÉxico

    Nov 1, 2011, 00:00

  • PHP86 Incorporating the Patient Perspective Into the Health Care Process- Experience from the C.A.T. Health System

    Nov 1, 2011, 00:00

  • PSY5 A Systematic Review of Tapentadol in Chronic Moderate to Severe Pain

    Nov 1, 2011, 00:00

  • PRM21 Validating a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision Making

    Nov 1, 2011, 00:00

  • PCV8 Effect of SIADH on Patient Outcomes and Health Care Resource Utilization in Hospitalized Patients

    Nov 1, 2011, 00:00

  • PMH8 US Government Initiatives for Supporting Comparative Effectiveness Research, An Example from Project Libra

    Nov 1, 2011, 00:00

  • PDB70 LOW-Dose Pioglitazone Utilisation in Patients with Type 2 Diabetes Mellitus in the United Kingdom

    Nov 1, 2011, 00:00

  • PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)

    Nov 1, 2011, 00:00

  • PRM26 A Literature Review of Methods Used to Estimate Mean Preference-Based Utilities for Comorbidities Using Published Summary Statistics

    Nov 1, 2011, 00:00

  • PHP23 Orphan Drug Access in Medicare Plans in the United States

    Nov 1, 2011, 00:00

  • PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis- The Case of Epilepsy in France

    Nov 1, 2011, 00:00

  • PCV24 Pharmacoepidemiology and Pharmacoeconomic Aspects of Use of ACE Inhibitors in Serbia Compared with Montenegro in 2009

    Nov 1, 2011, 00:00

  • EX3 Incremental Cost of Implementing A Care Program for People with Type 2 Diabetes in Argentina

    Nov 1, 2011, 00:00

  • PCN68 Cost-Effectiveness and Quality of Life Analysis of the Multicenter Itac02-01 Study- Prospective Randomized Comparison of Reduced Intensity Versus Non-Myeloablative Conditioning Regimen for Matched Related Allogeneic Stem Cell Transpla ...

    Nov 1, 2011, 00:00

  • PCN9 Adverse Events Among Patients with Metastatic Colorectal Cancer Treated with Monoclonal antibodies in Clinical Practice

    Nov 1, 2011, 00:00

  • PMH54 Quality of Life as a Predictor of Clinical Outcome- Example in Schizophrenia

    Nov 1, 2011, 00:00

  • PCV103 Estimating the Impact of Adherence to Allopurinol Therapy on Cardiovascular Outcomes in Gout Patients Using the Health Improvement Network (THIN) General Practice Database

    Nov 1, 2011, 00:00

  • PCN10 Comorbid Cardiovascular Diseases in Patients with Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile Neutropaenia

    Nov 1, 2011, 00:00

  • PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain

    Nov 1, 2011, 00:00

  • PIN113 A New Framework for Understanding the Impact of Hepatitis C and Its Treatment on Quality of Life

    Nov 1, 2011, 00:00

  • PRM67 What EPRO Modality is Appropriate for Your Study?

    Nov 1, 2011, 00:00

  • PSS4 Longer Term Patient Benefits of Polyquad® Preservative Instead of Benzalkonium Chloride in Prostaglandin Eye Drops- A Microsimulation Model in Ocular Hypertension and Open-Angle Glaucoma

    Nov 1, 2011, 00:00

  • PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life- Final Results

    Nov 1, 2011, 00:00

  • PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III Trial

    Nov 1, 2011, 00:00

  • PIN111 Dynamic Modeling of Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccination Against Streptococcus Pneumoniae in Taiwan

    Nov 1, 2011, 00:00

  • PRS44 Cost Utility Analysis of Omalizumab Therapy for Severe Asthma Patients in Thailand

    Nov 1, 2011, 00:00

  • ISPOR 3rd Latin America Conference Research Abstracts Author Index

    Nov 1, 2011, 00:00

  • PCV78 A Cost-Effectiveness Analysis of Clopidogrel Versus Aspirin in Patients with Atherothrombosis in Greece

    Nov 1, 2011, 00:00

  • PSS8 Advanced Cutaneous Melanoma in the UK- A Systematic Review

    Nov 1, 2011, 00:00

  • PRM8 Could Corporate Social Responsibility Predict Pharmaceutical Corporate Financial performance?

    Nov 1, 2011, 00:00

  • PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United States

    Nov 1, 2011, 00:00

  • PMS9 Prevalence of Shoulder Osteoarthistis and Treatment in A Large US Managed Care Population

    Nov 1, 2011, 00:00

  • PCN42 Treatment Costs of Bone Metastases in Patients with Lung Cancer- Results From A French Prospective, Observational, Multicenter Study (GFPC 0601)

    Nov 1, 2011, 00:00

  • PRM31 Data Pooling of Patient-Reported Outcomes in Clinical Trials- Evaluation of Structual Equation Modelling for Assessing Equivalence

    Nov 1, 2011, 00:00

  • PGI14 Resource Use and Cost of Hepatitis C Related Care in Belgium

    Nov 1, 2011, 00:00

  • PSY5 Estudio Costo-Efectividad Del Parche De LidocaÍna Como Terapia Adyuvante A Pregabalina Y Gabapentina En El Manejo Del Dolor NEUROPÁtico PERIFÉrico En El Hospital San José De Bogotá D.C. Enero-Diciembre 2010

    Nov 1, 2011, 00:00

  • PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los Costos

    Nov 1, 2011, 00:00

  • PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in Dystonia

    Nov 1, 2011, 00:00

  • PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

    Nov 1, 2011, 00:00

  • PSY9 A Budget Impact Model of Rituximab Introduction in Wegener Granulomatosis Therapies

    Nov 1, 2011, 00:00

  • PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU Countries

    Nov 1, 2011, 00:00

  • PGI32 An Investigation into the Extensive Spectrum of Agents Used for the Management of Post-Operative Ileus

    Nov 1, 2011, 00:00

  • PGI31 The Maintenance of Work-related Productivity During One Year of MMX Mesalamine Treatment for Patients with Quiescent Ulcerative Colitis

    Nov 1, 2011, 00:00

  • PHP79 What Are the Research Priorities in the Spanish National Health System? A Comparison of Economic Evaluations of Health Care Interventions and Public-Funded Research

    Nov 1, 2011, 00:00

  • PCN122 Disclosing Traditional CM) Use to the Health Care Providers- A Qualitative Study Among Cancer Patients at a Local Hospital in Malaysia

    Nov 1, 2011, 00:00

  • PCN41 Hospital Health Care Costs for the Management of HER2-Positive Breast Cancer with Brain Metastases

    Nov 1, 2011, 00:00

  • PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to Placebo

    Nov 1, 2011, 00:00

  • PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care- Comparing Infliximab to Methotrexate and Systemic Steroids

    Nov 1, 2011, 00:00

  • PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Spain

    Nov 1, 2011, 00:00

  • PCN124 The Impact of Condition Labelling on Health State Values

    Nov 1, 2011, 00:00

  • PHP62 Establish Drugs Optimal Purchase Model

    Nov 1, 2011, 00:00

  • PSS15 Burden of Chronic Tinnitus in Hungary

    Nov 1, 2011, 00:00

  • PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung Cancer

    Nov 1, 2011, 00:00

  • PCN199 An Evaluation of Statistical Methods Used to Analyse Patient-Reported Outcomes (PRO) Data in Published Metastatic Cancer Studies

    Nov 1, 2011, 00:00

  • PR3 Industry Preparedness against German reforms

    Nov 1, 2011, 00:00

  • PCN51 Health Care Resources and Costs Across Lines of Therapies in Insured Patients with Metastatic Breast Cancer in the United States

    Nov 1, 2011, 00:00

  • PND3 Estimación Del proceso De procuración De órganos De Pacientes Con Muerte Cerebral En México 2009

    Nov 1, 2011, 00:00

  • PCN174 Variations in Drug Administration Costs for Stage III/IV NSCLC in Europe

    Nov 1, 2011, 00:00

  • EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela- Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)

    Nov 1, 2011, 00:00

  • PMD22 Economic Evaluation of Amino-Terminal pro-Brain Natriuretic Peptide (NT-proBNP) Test in Patients with Dyspnea attending to Emergency Department (ED) in Spain

    Nov 1, 2011, 00:00

  • PIN69 Methodological Challenges for Economic Evaluations of Vaccination Programs- The Case of Pertussis Booster Vaccination

    Nov 1, 2011, 00:00

  • PIN46 Cost-Effectiveness and Public Health Impact of Pneumococcal Vaccination in Malaysia

    Nov 1, 2011, 00:00

  • PCV52 Temporal Trends in the Hospital Burden of Atrial Fibrillation and Stroke on Secondary Care Costs in England Between 2006 and 2009

    Nov 1, 2011, 00:00

  • PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral Olanzapine

    Nov 1, 2011, 00:00

  • PMH44 Improving Health-Related Quality of Life for Patients with Refractory Post-Traumatic Stress Disorder- Use of Local Anesthetics Show Promise in a Clinical Case Series

    Nov 1, 2011, 00:00

  • PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in Bulgaria

    Nov 1, 2011, 00:00

  • PCV57 Epidemiological Structure, Socioeconomic Effects and Burden of Disease in Patients with Oral Anticoagulation and Atrial Fibrillation in Austria

    Nov 1, 2011, 00:00

  • PMS14 Cost of Etanercept, Adalimumab, and Infliximab Per Treated Patient Across Adult Indications Using Real-World Data

    Nov 1, 2011, 00:00

  • PHP144 Multi-Stakeholder Survey of Comparative Effectiveness Research Perceptions

    Nov 1, 2011, 00:00

  • PRS58 Treatment Outcomes of New Smear Positive Pulmonary Tuberculosis Patients in North East Libya

    Nov 1, 2011, 00:00

  • PIH17 Burden of Illness in Patients with Neural Tube Defects in Germany

    Nov 1, 2011, 00:00

  • PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes Patients

    Nov 1, 2011, 00:00

  • PHP32 Market Access Variation for Lifestyle Disease Drugs in Europe

    Nov 1, 2011, 00:00

  • PMH5 Empirically-Driven Definitions of “Good” “Moderate” and “Poor” Levels of Functioning in the Treatment of Schizophrenia

    Nov 1, 2011, 00:00

  • MT1 Impact of the Choice of Prior Distribution on relative Effect Sizes Using Bayesian Network Meta-Analysis

    Nov 1, 2011, 00:00

  • PSY30 Cost Effectiveness of Tramadol Versus Diclophenac in Pain Management After Cesarean Delivery

    Nov 1, 2011, 00:00

  • PMS18 Burden of Rheumatoid Arthritis in the Czech Republic – Direct and productivity Costs

    Nov 1, 2011, 00:00

  • PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder Symptoms

    Nov 1, 2011, 00:00

  • PC2 Estimation of Productivity Costs Using the Friction Cost Method- New Evidence Using National Data

    Nov 1, 2011, 00:00

  • PDB19 Prevalence of Diabetes Mellitus Among Patients with Vascular Complications in Poland

    Nov 1, 2011, 00:00

  • PHP33 Impact of 2011 German Health Care Reform on Global Market Access Strategies

    Nov 1, 2011, 00:00

  • PMH46 The Quality of Life of Children With ADHD and their Parents- Results of EQ-5D and Kidscreen-10

    Nov 1, 2011, 00:00

  • PCN145 Measurement Properties of the English and Chinese Versions of the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian Breast Cancer Patients

    Nov 1, 2011, 00:00

  • PHP11 The Use of Methylphenidate in A Group of Patients with Attention Deficit and Hyperactivity Disorder

    Nov 1, 2011, 00:00

  • PCN90 Cost-Effectiveness Analysis of Erlotinib Versus Docetaxel, Pemetrexed for Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer in Russia

    Nov 1, 2011, 00:00

  • PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care Environment

    Nov 1, 2011, 00:00

  • PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based Study

    Nov 1, 2011, 00:00

  • PCN155 The Challenges of Estimating Costs of Palliative Care- A Systematic Literature Review

    Nov 1, 2011, 00:00

  • PCN10 Analisis De Minimizacion De Costos Entre El Uso De Iopromide Mediante Un Sistema De Aplicacion En Cascada (SIAC) Frente Al Uso De Otros Medios De Contraste Convencionales En Radiologia Invasiva En Colombia

    Nov 1, 2011, 00:00

  • PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b- A Cost-Effectiveness Analysis for the Portuguese NHS Setting

    Nov 1, 2011, 00:00

  • PIN102 National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program- Analysis Versus Canada and Australia

    Nov 1, 2011, 00:00

  • PCN192 BIA Results Could Stop Introduction of Cost-Effectiveness Therapy into Standard Treatment - Example from Croatia

    Nov 1, 2011, 00:00

  • PMS7 Direct Treatment-Cost of Patients with Rheumatoid Arthritis in Medellin, Colombia

    Nov 1, 2011, 00:00

  • PSS30 Assessment of Utility Loss From Diabetic Macular Edema Based on Restore Trial

    Nov 1, 2011, 00:00

  • PMH22 Economic Burden of Attention Deficit Hyperactivity Disorder in Children and Adolescents in Europe

    Nov 1, 2011, 00:00

  • PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PCN32 Cost Savings With Bevacizumab Compared to Sunitinib in the Treatment of MRCC

    Nov 1, 2011, 00:00

  • PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing Technologies

    Nov 1, 2011, 00:00

  • PIN98 Evaluating Optimal Treatment Outcomes of Antiviral Therapy in Hepatitis C for Prior Null Responders in the Era of First Generation Protease Inhibitors

    Nov 1, 2011, 00:00

  • PCN63 Cost-Effectiveness of Sunitinib in Patients with Advanced or Metastatic Pancreatic Neuroendocrine Tumors in Portugal

    Nov 1, 2011, 00:00

  • PRM29 Translation and Validation Study of Morisky Medication Adherence Scale (MMAS)- The Urdu Version

    Nov 1, 2011, 00:00

  • PIN104 Pro's in Evaluating Resource Utilisation and Absenteeism in People Receiving Influenza Vaccination

    Nov 1, 2011, 00:00

  • PSU17 Cost-Effectiveness of DSAEK Versus PK for Corneal Endothelialdisease

    Nov 1, 2011, 00:00

  • PCN6 Impact of 5-HT3 Receptor Antagonist Selection Within Triple Antiemetic Regimens on the Risk of Uncontrolled Chemotherapy-Induced Nausea in Patients with Cancer Treated with Highly Emetogenic Chemotherapy

    Nov 1, 2011, 00:00

  • PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil- A Real World Data Analysis

    Nov 1, 2011, 00:00

  • PMS53 Work Productivity and Productivity Costs of Patients with Ankylosing Spondylitis in the Czech Republic

    Nov 1, 2011, 00:00

  • PIH15 Estimating Herpes Zoster Disease Burden in Germany

    Nov 1, 2011, 00:00

  • PRM65 Should We Aggregate Cost-Effectiveness over an Intervention's Entire Implementation Lifetime?

    Nov 1, 2011, 00:00

  • PCV140 The Impact of National Mass Screening Program on Health Service Utilizations and Medical Expenses- In the Case of Hypertension Complications

    Nov 1, 2011, 00:00

  • PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in Development

    Nov 1, 2011, 00:00

  • PCN31 Sequential Treatment of Metastatic Renal Cell Carcinoma with Targeted Therapies- Adverse Events Associated Costs, from the Public and Private Perspectives in Brazil

    Nov 1, 2011, 00:00

  • PMS11 Establishing the Safety of Tumour Necrosis Factor Inhibition (TNF-I) in Rheumatoid Arthritis (RA) from an Analysis of Real World Data

    Nov 1, 2011, 00:00

  • PDB34 Medical Treatment Costs Attributable to Obesity in Diabetic Patients in the United States

    Nov 1, 2011, 00:00

  • PCN120 The Natural History of Fludarabine-Refractory Chronic Lymphocytic Leukemia Patients Who Fail Alemtuzumab or Have Bulky Lymphadenopathy – A European Perspective

    Nov 1, 2011, 00:00

  • PCN74 Cost-Effectiveness Analysis of Chemoprevention for Colorectal Cancer by Low Dose Aspirin in South Korea

    Nov 1, 2011, 00:00

  • PCN38 Economic Evaluation of Darbepoetin Alpha in the Management of Patients with Chemotherapy Induced Anemia (CIA) in Greece

    Nov 1, 2011, 00:00

  • PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment- Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available Patients

    Nov 1, 2011, 00:00

  • PMH42 Cost-Utility Analysis of Paliperidone Palmitate Long Acting Injection(PLAI) Versus Oral Atypical Antipsychotics in Non-Adherent Schizophrenia Patients

    Nov 1, 2011, 00:00

  • PCN17 Correlations Between Surrogate End Points and overall Survival in Advanced or Metastatic Breast Cancer

    Nov 1, 2011, 00:00

  • PUK6 BPH Patients Treated with Phytotherapy in Portugal- Results at Six Months

    Nov 1, 2011, 00:00

  • PMS49 Cost-Effectiveness of Rituximab in the Treatment of RA Patients in the Netherlands

    Nov 1, 2011, 00:00

  • PDB18 Australia- Management of the Diabetic Foot with Pedimed® Under Real Use Conditions

    Nov 1, 2011, 00:00

  • PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel Therapy

    Nov 1, 2011, 00:00

  • PSU27 Fracture Related Treatments After Primary Surgical Interventions of Hip Fracture Eight Years Follow Up

    Nov 1, 2011, 00:00

  • PIN57 Cost-Effectiveness of the New Guidelines for the Prevention of Mother to Child Transmission of HIV in Uganda

    Nov 1, 2011, 00:00

  • PHP34 Pricing Insights Across Therapy Areas and European Countries - A Discussion of International Price References and Implications for Parallel Trade and Prescription Patterns of Pharmaceutical Products

    Nov 1, 2011, 00:00

  • PMD74 Home Dialysis Modalities- The Development of A Framework to Identify and Quantify Favourable Renal Policy and Reimbursement Factors

    Nov 1, 2011, 00:00

  • PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011

    Nov 1, 2011, 00:00

  • PMD67 The Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Elderly Patients with Severe Aortic Stenosis Who are Contraindicated for Conventional Surgical Aortic Valve replacement in the United Kingdom

    Nov 1, 2011, 00:00

  • PSY13 Efecto de un Programa de Atención Farmacéutica Para Pacientes Con Sobrepeso Y Obesos

    Nov 1, 2011, 00:00

  • PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine- The Belgian Case

    Nov 1, 2011, 00:00

  • PRM6 Translation of Patient-Reported Outcomes Measures Translatability Review And Item Definition

    Nov 1, 2011, 00:00

  • PCN132 A Development of Quality Indicators for Evaluating Home Palliative Care and Their Relation with Bereaved Family Satisfaction

    Nov 1, 2011, 00:00

  • PMS76 Treatment Patterns Among Patients with Shoulder Osteoarthistis

    Nov 1, 2011, 00:00

  • PIH63 The KIGS Quality Insight Program Assessing the Quality of Care for Short Children Treated with Growth Hormone Using the Output from a Large Pharmaco-Epidemiological Survey

    Nov 1, 2011, 00:00

  • PIN100 Why Don't Health Practitioners Prescribe Rationally in Malaria? A qualitative Study from Pakistan

    Nov 1, 2011, 00:00

  • PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase- Five-Years Follow-up Simulated Cohort

    Nov 1, 2011, 00:00

  • PCV131 Cardiovascular Drug Utilization in Relation to Age in Nis Region

    Nov 1, 2011, 00:00

  • PHP26 A SatisfaÇÃo Dos Profissionais De SaÚde vs A SatisfaÇÃo Dos Utentes Em Unidades De Cuidados Continuados

    Nov 1, 2011, 00:00

  • PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in Uganda

    Nov 1, 2011, 00:00

  • PSU8 Risks and Benefits of Acrysof® Cachet™ Implantation in High Myopia (≥-6 DIOPTRE)- A Systematic Literature Review

    Nov 1, 2011, 00:00

  • PDB8 Cost-Effectiveness Study of Oral Hypoglycemic Agents in Outpatients Diagnosed with Type-2 Diabetes Attending a Primary Care Public Clinic in Mexico City

    Nov 1, 2011, 00:00

  • PMS13 The Burden of Juvenile Idiopatic Arthritis (JIA) in Russia- A Retrospective Review of Direct and Indirect Costs

    Nov 1, 2011, 00:00

  • PRS60 The Impact of Severe Poor-Controlled Asthma On Patients' Quality of Life Control Study

    Nov 1, 2011, 00:00

  • PSY6 The Health Improvement Network (Thin) 2008-2009 Estimates of Psoriasis Incidence and Prevalence in Uk Primary Care

    Nov 1, 2011, 00:00

  • PMS6 A Network Meta-analysis of Biologic Treatments in TNF-IR Rheumatoid Arthritis Patients

    Nov 1, 2011, 00:00

  • PSU22 Performance of the Functional Assessment of Visual Tasks (VISTAS-18) among Cataract Patients Receiving Monofocal and Multifocal Intraocular Lens Implants

    Nov 1, 2011, 00:00

  • PRM30 A Comparison of the Patientslikeme Quality of Life Questionnaire (PLMQOL) with the Rand SF-36

    Nov 1, 2011, 00:00

  • PIN3 Pursuing Financial Sustainability To Fulfill The Millenium Development Goal Six In A Fragmented SYSTEM. The Experience Of The Universal Access To Antiretroviral Drugs In MÉxico 2007-2009

    Nov 1, 2011, 00:00

  • PIN7 The Comparative Efficacy of Telaprevir Versus Boceprevir in Treatment-Naive and Treatment-Experienced Patients with Genotype 1 Chronic Hepatitis

    Nov 1, 2011, 00:00

  • PIN101 New Insights on the Spread of Influenza Through Agent Based Epidemic Modeling

    Nov 1, 2011, 00:00

  • PGI25 Chronic Hepatitis C (CHC) Related Flu-like Symptoms; Development of a Patient Report Outcome (PRO) Measure and Results from Pilot Efficacy Studies

    Nov 1, 2011, 00:00

  • PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased Adherence

    Nov 1, 2011, 00:00

  • PGI20 Pharmacoeconomic Study of Glutamine Dipeptide Usage During Total Parenteral Nutrition (TPN)

    Nov 1, 2011, 00:00

  • PCN61 Impact of Appropriate Treatment Informed by EGFR Mutation Status on Patient Outcomes from Diagnosis to Death in Advanced Non-Small Cell Lung Cancer

    Nov 1, 2011, 00:00

  • PIN21 Clinico-Economic Evaluation of Treatment of Community-Acquired Pneumonia (CAP) Complicated by Sepsis with Moxifloxacin Compared to Ceftriaxone + Azithromycin

    Nov 1, 2011, 00:00

  • PND63 Drug Prescription in and Hospitalization of Refractory Focal Epilepsy Patients in the German Neurotransdata (NTD) Neurologists' Network – is There An Unmet Need?

    Nov 1, 2011, 00:00

  • PCV20 Duration of Action of Aliskiren in Hypertensive Patients with Diabetes – Implications for Control of Blood Pressure in Real-World Use in Imperfectly Adherent Patients

    Nov 1, 2011, 00:00

  • PDB72 The Burden of Hypoglycaemia in Secondary Care in England

    Nov 1, 2011, 00:00

  • PHP114 Performance Indicators of Intensive Care in Hungary

    Nov 1, 2011, 00:00

  • PMD36 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in the Netherlands

    Nov 1, 2011, 00:00

  • PMS67 Determining the True Impact of Dupuytren'S Disease- A Qualitative Study

    Nov 1, 2011, 00:00

  • PMS78 Measurement Strategy for Kyphosis- New Evidence from Patients and Physicians

    Nov 1, 2011, 00:00

  • PGI2 Cost-Effectiveness Analysis of the Use of Adalimumab for the Treatment of Crohn's Disease (CD) in Mexico

    Nov 1, 2011, 00:00

  • PMD40 Cost Effectiveness of Fractional Flow reserve Measurement in Multivessel Coronary Artery Disease in Belgium and France

    Nov 1, 2011, 00:00

  • PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients- A Within Trial Analysis from the Perspective of the ...

    Nov 1, 2011, 00:00

  • PMS19 The Economic Burden of Post-Menopausal Osteoporosis and Related Fractures in Greece

    Nov 1, 2011, 00:00

  • PIH1 Comparison of Unintended Pregnancy Rates in Users of 84/7, 21/7, and 24/4 Oral Contraceptive Regimens

    Nov 1, 2011, 00:00

  • PMD21 The Clinical and Economic Benefits of Spinal Cord Stimulation in the Treatment of Failed Back Surgery Syndrome (Precise Study)

    Nov 1, 2011, 00:00

  • PMS44 Cost-Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis in Scotland

    Nov 1, 2011, 00:00

  • PMD83 Using Five Existing Models to Comprehensively Model the Cost-Effectiveness of A High Definition CT Scanner in A Coronary Artery Disease Population- A Nice Diagnostic Guidance Project

    Nov 1, 2011, 00:00

  • PSS41 Impact on Quality of Patients With Active and Inactive Psoriasis in Spain

    Nov 1, 2011, 00:00

  • PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions

    Nov 1, 2011, 00:00

  • PSU28 Economic Impact of Stereotactic Radiosurgery for Malignant Intracranial Brain Tumors

    Nov 1, 2011, 00:00

  • PCN127 Health State Utility Assessment for Breast Cancer

    Nov 1, 2011, 00:00

  • PHP17 Mexico'S National and Institutional Essential Medicine Lists

    Nov 1, 2011, 00:00

  • PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)

    Nov 1, 2011, 00:00

  • PMS35 A Cost-Effectiveness Analysis of Denosumab for the Treatment of Post-Menopausal Osteoporosis in Greece

    Nov 1, 2011, 00:00

  • PSS29 Treatment Patterns of Psoriasis Patients and Trends Over Time

    Nov 1, 2011, 00:00

  • PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive Patients

    Nov 1, 2011, 00:00

  • PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain

    Nov 1, 2011, 00:00

  • PUK15 A Simulation Model of The Effects of Treatments for Secondary Hyperparathyroidism on Mortality

    Nov 1, 2011, 00:00

  • PMH78 Retrospective Prescription Analysis of Dementia in a South Indian Psychiatric Hopital

    Nov 1, 2011, 00:00

  • PMH82 Examining Variability in Depression Among Pre-Retirees- Innovative Analytic Methods Applied to Observational Data

    Nov 1, 2011, 00:00

  • PDB17 Off-Label and Non-Licensed Endocrinology Medicine Use in Turkey- A Retrospective Analysis of Computer Records in the Turkish Ministry of Health

    Nov 1, 2011, 00:00

  • PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United Kingdom

    Nov 1, 2011, 00:00

  • PRS3 The Effect Of Aat Replacement Therapy on Patient Length And Quality Of Life - a Markov Model

    Nov 1, 2011, 00:00

  • PHP48 Os Motivos Que Levam O JudiciÁrio A Determinar Que Os Planos De SaÚde ForneÇam MedicaÇÃo oral Em Oncologia

    Nov 1, 2011, 00:00

  • PHP83 The Economic Burden of Disease Related Malnutrition in Europe

    Nov 1, 2011, 00:00

  • PMD32 Cost Effectiveness of Cervical Cancer Screening in Serbia- A Comparison of Screening Policies

    Nov 1, 2011, 00:00

  • MA3 Mapping the Diabetes Health profile (DHP-18) onto the EQ-5D and SF-6D Generic Preference Based Measures of Health

    Nov 1, 2011, 00:00

  • PCN112 Cost-Utility of Treatment for Acute Lymphoblastic Leukemia (ALL) in Childhood

    Nov 1, 2011, 00:00

  • PHP169 The Values of General Practitioners/Family Physicians Should Be Fostered into Other Clinicians- A Research Study

    Nov 1, 2011, 00:00

  • PIN71 Pharmacoeconomic Analysis of Treatment of Community-Acquired Pneumonia (CAP)

    Nov 1, 2011, 00:00

  • MT2 The Use of Continuous Data versus Categorical Data in MTC- The Case of HAQ Multiplier in Rheumatoid Arthritis

    Nov 1, 2011, 00:00

  • PSY15 Striving for Affordable Treatments Within the Greek Environment- Do Epoetin Biosimilars Help?

    Nov 1, 2011, 00:00

  • PMD76 Are Health Technology Assessments of Medical Devices Catching up with Pharmaceuticals?

    Nov 1, 2011, 00:00

  • PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along Spain

    Nov 1, 2011, 00:00

  • PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 Years

    Nov 1, 2011, 00:00

  • PND45 Development and Validation of the Multiple Sclerosis Rating Scale-Revised (MSRS-R)

    Nov 1, 2011, 00:00

  • PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in Spain

    Nov 1, 2011, 00:00

  • PHP147 Opinions on Market Access Needs Differ Between Cultures and Stakeholder Sectors – Results of a Survey of ISPOR Delegates

    Nov 1, 2011, 00:00

  • PRM55 A New Approach to Modeling Cancer Recurrence and Follow-Up

    Nov 1, 2011, 00:00

  • PIN96 Does Connecting Tobacco Cessation Intervention in Tuberculosis Care Improve Quality of Life Outcomes?

    Nov 1, 2011, 00:00

  • PCN126 Which Factors Can Affect Utilities?

    Nov 1, 2011, 00:00

  • PCN13 Treatment of Patients with Multiple Myeloma (TLN-Registry)- A “Real Life” Overview of Treatment by Office-Based Oncologists in Germany

    Nov 1, 2011, 00:00

  • PMD14 Budget Impact analysis of Two Drug-Eluting Stents for Diabetic Patients in Spain

    Nov 1, 2011, 00:00

  • PHP38 Market Access for Pharmaceuticals in UK- Number and Speed of Drug Reviews to Improve After Introduction of Value Based Pricing

    Nov 1, 2011, 00:00

  • PHP3 A Review of Breast Cancer (BC) Care and Outcomes in Latin America Caribbean (LAC)

    Nov 1, 2011, 00:00

  • PC4 Health Services Utilization, Work absenteeism and Costs of Pandemic influenza A (H1N1)

    Nov 1, 2011, 00:00

  • PCV10 Un Estudio De Minimizacion De Costos Para Evaluar El Tratamiento Con Metoprolol En Pacientes Con Hipertension Arterial En México

    Nov 1, 2011, 00:00

  • PMS70 Evaluation of Prescribed Pain Medications Prior to the Initiation of Duloxetine Therapy in a Commercially Insured Population

    Nov 1, 2011, 00:00

  • PDB4 Characterization of the Risk for Urinary Tract Infections in US Patients with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PCV126 Multidimensional Non-Interventional Study to Assess Current Practice, Utilization of Resources and Costs Related to Anticoagulation Treatment in Poland – “Economedica”

    Nov 1, 2011, 00:00

  • PRM51 Nonparametric Regression Analysis Controls Cost Analysis in Data with Outliers

    Nov 1, 2011, 00:00

  • PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term Patients

    Nov 1, 2011, 00:00

  • PRS14 Estimating the Budget Impact of Introducing Indacaterol in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) from the Public Payer Perspective in SÃo Paulo

    Nov 1, 2011, 00:00

  • PCN16 Disease Burden and Treatment outcomes in Second-Line Therapy of Patients with Estrogen-Receptor Positive (ER+) Advanced Breast Cancer- A Review of the Literature

    Nov 1, 2011, 00:00

  • PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in France

    Nov 1, 2011, 00:00

  • PIN41 Cost-Benefit Analysis of Regional Procured Essential Medicines in the Southern African Development Community (SADC) with a Focus on Access to Antiretroviral Drugs

    Nov 1, 2011, 00:00

  • PSS38 3-D Study - Description of the Care of the Dental Pain

    Nov 1, 2011, 00:00

  • QA2 Analisis De Costo-Utilidad De Rituximab Posterior Al Fallo Por Anti-Tnf En Artritis Reumatoide Para Colombia

    Nov 1, 2011, 00:00

  • PRS34 Cost-Effectiveness of Roflumilast (DAXAS®) in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) in Spain

    Nov 1, 2011, 00:00

  • PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) Measures

    Nov 1, 2011, 00:00

  • PIN44 Cost-Effectiveness of Quadrivalent HPV Vaccination in Germany Using A Dynamic Transmission Model

    Nov 1, 2011, 00:00

  • PCV14 Mixed Treatment Comparison of Dronedarone, Amiodarone and Sotalol for the Management of Atrial Fibrillation in Australia

    Nov 1, 2011, 00:00

  • PCV5 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with No Treatment Under the Brazilian Private Health Care System Per ...

    Nov 1, 2011, 00:00

  • ISPOR 3rd Latin America conference disclosure information for reserch presentations

    Nov 1, 2011, 00:00

  • PHP112 Inter-Individual Country Variability in Monoclonal Antibodies (MABS) Reimbursement and Coverage Following EMA Approval

    Nov 1, 2011, 00:00

  • PND67 A Mixed-Effects Piecewise Linear Model of the Rate of Lung Function Decline Before and After the Clinical Use of Dornase Alfa in an Observational Study of Cystic Fibrosis

    Nov 1, 2011, 00:00

  • PIH57 Pediatric Daycare in Belgium

    Nov 1, 2011, 00:00

  • PMD35 Cost-Effectiveness Analysis of the Corail Hip System for Primary total Hip Arthroplasty in Spain

    Nov 1, 2011, 00:00

  • PCN142 Methodological Limitations of Patient-Reported Outcome Measures (PROMs) in oncology- A Meta-Review

    Nov 1, 2011, 00:00

  • PCN72 Cost - Effectiveness Analysis of Cervical Cancer Vaccination Strategies in Spain

    Nov 1, 2011, 00:00

  • PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD- The Use of Mixture Models

    Nov 1, 2011, 00:00

  • PRS76 Systematic Literature Review of Conceptual Models to Inform Economic Modelling in COPD

    Nov 1, 2011, 00:00

  • PCV98 Estimating Willingness to Pay for Hypertension Outpatient Benefit Packages

    Nov 1, 2011, 00:00

  • PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branc ...

    Nov 1, 2011, 00:00

  • UT4 Comparison Of The Performance Of EQ-5D and SF-6D In Patients With Chronic Pain –Results From 3 Randomized Controlled Trials

    Nov 1, 2011, 00:00

  • PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in Poland

    Nov 1, 2011, 00:00

  • PMH39 Cost Effectiveness of A Collaboratieve Care Stepped intervention for Anxiety Disorders in the Primairy Care Setting

    Nov 1, 2011, 00:00

  • PND15 Economic Burden of Chronic Migraine in Taiwan

    Nov 1, 2011, 00:00

  • CN1 Mean Versus Median Overall Survival (OS) For Describing Value of New Cancer Therapies- A Case Study

    Nov 1, 2011, 00:00

  • PRS59 Quality of Life in Severe Persistent Uncontrolled Asthma- Patients and Caregivers in the Spanish Pediatric Population- A Prex Study

    Nov 1, 2011, 00:00

  • PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

    Nov 1, 2011, 00:00

  • HT4 What Determines the Recommendations Issued by Polish Health Technology Agency (AHTAPol)?

    Nov 1, 2011, 00:00

  • PCN56 Are Out-of-Pocket Payments for Oral Oncologic Therapies Too High? Updated Results From A U.S. Claims Data Analysis

    Nov 1, 2011, 00:00

  • PMH36 Cost-Effectiveness of Depot Flupentixol Versus Long-Acting Risperidone – A Markov Model Parameterized Using Administrative Data

    Nov 1, 2011, 00:00

  • PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In Sweden

    Nov 1, 2011, 00:00

  • PDB28 The Roleof Diabetes and Body Mass Index on Medical Expenses, an Analysis of the Medical Expenditure Panel Survey, 2008

    Nov 1, 2011, 00:00

  • PMH76 Patterns and Determinants of Sickness Absence Among Users of Antidepressants in a Danish Working Population

    Nov 1, 2011, 00:00

  • PIN14 Prescribing Patterns of Sebivo® (Telbivudine)- A Survey Among Physicians in Selected European Countries

    Nov 1, 2011, 00:00

  • PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2011, 00:00

  • PRS27 Trends in Uk Smoking Cessation Prescription Expenditure Over Time - a Thin Database Study

    Nov 1, 2011, 00:00

  • PIN91 Sensitivity of Pro's in Evaluating Adverse Events in People Receiving Influenza Vaccination

    Nov 1, 2011, 00:00

  • PIH43 Changes in Health-Related Behaviours and their Impact on Academic Achievement and Health-Related Quality of Life (HRQOL) Among Spanish Adolescents

    Nov 1, 2011, 00:00

  • PHP24 How Does the Committee to Evaluate Drugs (CED) Make Decisions about Ambulatory Pharmaceutical Funding in Ontario?

    Nov 1, 2011, 00:00

  • PMD9 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients- Systematic Review

    Nov 1, 2011, 00:00

  • PCV142 A Review of the Primary Care Prescribing of Dabigatran Etexilate and Rivaroxaban in Ireland

    Nov 1, 2011, 00:00

  • PHP35 Is Value Based Pricing Executed In Real Life Situation? – Global Perspectives

    Nov 1, 2011, 00:00

  • PSS36 Demonstrating Conceptual Equivalen Translation of the Cu-Q2Ol From Italian into English

    Nov 1, 2011, 00:00

  • PGI30 Comparison of Health Related Quality of Life Between Hepatitis, Cirrhosis, Liver Transplantation and Hepatic Carcinoma- Results of the Come Study

    Nov 1, 2011, 00:00

  • PCN40 Health Care Resources Utilization and Costs in Metastatic Melanoma

    Nov 1, 2011, 00:00

  • PSU7 Implications of Alloarthroplastic Infections in Hip and Knee Surgery

    Nov 1, 2011, 00:00

  • PMS34 Cost-Effectiveness Analysis of Bio- Hyaluronic Acid (HA) in Patients with Knee Osteoarthritis in Mexico

    Nov 1, 2011, 00:00

  • PRS17 Prevalence and Cost of Severe Chronic Hand Eczema Refractory to Topical Potent Corticosteroids

    Nov 1, 2011, 00:00

  • PRS70 Real World Evaluation of Different Smoking Cessation Service Models in England

    Nov 1, 2011, 00:00

  • PSY14 Differences in Outpatient Care Among Fibromyalgia Patients on Duloxetine Versus Pregabalin

    Nov 1, 2011, 00:00

  • PMH4 Economic Assessment Of Major Depressive Disorder Treatment Under Different Therapeutic Classes At Issste

    Nov 1, 2011, 00:00

  • PCV65 Clinico-Economic Evaluation of Complex Cardiovascular Therapy with Magnesium Orotate in Patients with Chronic Heart Failure Versus Standard Therapy in Ukraine

    Nov 1, 2011, 00:00

  • PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)

    Nov 1, 2011, 00:00

  • PHP88 Societal Unmet Needs within Spain

    Nov 1, 2011, 00:00

  • PGI24 Burden of Gastroesophageal Reflux Disease Among Patients With Persistent Symptoms Despite Proton Pump Inhibitor Therapy- An Observational Study in France

    Nov 1, 2011, 00:00

  • PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis- a Mixed Treatment Meta-Analysis

    Nov 1, 2011, 00:00

  • PCN161 The Lost Art of Needs Assessment- The Case of Hepatocellular Carcinoma (HCC) Control in European Countries

    Nov 1, 2011, 00:00

  • PRM28 Bayesian Inference in Mixed Treatment Comparisons (MTC) with Continuous Outcomes

    Nov 1, 2011, 00:00

  • PCN182 What Kind of Changes Did the Publication of Two Large-Scale RCTs Lead to in Prostate Cancer Screening Guidelines?

    Nov 1, 2011, 00:00

  • PIH39 How Do Postmenopausal Women Describe Breast Pain and Breakthrough Bleeding Associated with Hormonal Treatments for Menopausal Symptoms- Qualitative Interviews with Postmenopausal Women in the United States, China, Mexico and Italy

    Nov 1, 2011, 00:00

  • PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS- A Meta-Analysis Combining Published and Unpublished Data

    Nov 1, 2011, 00:00

  • PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) Perspective

    Nov 1, 2011, 00:00

  • PGI1 incidence and Cost of Treatment-Emergent Comorbid Events in an Insured Population Receiving Treatment for Chronic Hepatitis C (CHC) Virus Infection

    Nov 1, 2011, 00:00

  • PMD68 Purchasing and Adopting Cardiovascular Devices- A Global Survey

    Nov 1, 2011, 00:00

  • PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant Therapy

    Nov 1, 2011, 00:00

  • PSU19 the Doors-Study of On-Pump Versus Off-Pump Coronary Artery bypass Grafting- A Post Hoc Analysis of Methods for Multiple Imputation of Missing Data in Economic Evaluation

    Nov 1, 2011, 00:00

  • PCV134 Concomitant Medciation Use in US Adults on Statin Therapy- Findings from a Multi-Employer Claims Database

    Nov 1, 2011, 00:00

  • VA2 Cost Effectiveness Analysis of Vaccination Programs With 10-Valent (PCV10) and 13-Valent (PCV13) Pneumococcal Vaccines in Bogotá, Colombia

    Nov 1, 2011, 00:00

  • PRM39 Identification of Diseases for EQ-5D Bolt-on Item Development- An Empirical Approach

    Nov 1, 2011, 00:00

  • PHP155 Review of Cost Effectiveness Models of High Budget Impact Drugs

    Nov 1, 2011, 00:00

  • PMH62 An Examination of the Association Between Antidepressant-Related Weight Gain and Various Aspects of Worker Productivity

    Nov 1, 2011, 00:00

  • PMD73 Comparisons of Anaphylactoid Reactions Associated With Different Gadolinium Products and Iodinated Contast Media Using the FDA's Adverse Event Reporting System

    Nov 1, 2011, 00:00

  • PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients with Overactive Bladder in the United Kingdom

    Nov 1, 2011, 00:00

  • PRS21 Resource Utilization and Associated Costs of Community Acquired Pneumonia (CAP) in Adults- Observational Study in a Population Setting in a Well Defined Area of Barcelona (Badalona, Spain)

    Nov 1, 2011, 00:00

  • PRM12 An Application of a Proposed Framework for Formulary Listing in Low-income Countries- Case of Côte d'Ivoire

    Nov 1, 2011, 00:00

  • PSS2 Prevalence, Demographics and Treatment Characteristics of Visual Impairment Due to Diabetic Macular Edema in A Representative Canadian Cohort

    Nov 1, 2011, 00:00

  • PCN89 Public Health Impact of Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Sao Paulo, Brazil Using A Transmission Dynamic Model

    Nov 1, 2011, 00:00

  • PCV61 are Hospital Costs for Stroke Underestimated in Spain?

    Nov 1, 2011, 00:00

  • AD3 Assessing The Compliance And Persistence of Allergen Immunotherapy In Allergic Rhinitis Using A Retrospective Pharmacy Database From The Netherlands

    Nov 1, 2011, 00:00

  • PCV90 Development of an Institutional Cost of Care Model for Anticoagulation Management of Patients with Warfarin Versus Novel Oral Agents

    Nov 1, 2011, 00:00

  • PCV36 High Dose and Long-Term Safety of Systemic Corticosteroids in the Treatment of Polymylagia Rheumatica and Vasculitis- A Systematic Review

    Nov 1, 2011, 00:00

  • TP1 Prevalence of Lipid Abnormalities Before and After Introduction of Lipid Modifying Therapy Among Mexican Patients

    Nov 1, 2011, 00:00

  • PCV59 Annual Medical Expenditure and Mortality Related to Acute Coronary Syndrome (ACS) in the United Kingdom – A Systematic Review

    Nov 1, 2011, 00:00

  • PCV2 Evaluation of the prophylaxis Patterns and 90 Day outcome Events in Hospitalized Medically Ill Patients

    Nov 1, 2011, 00:00

  • PCN24 Budget Impact Model for Rare Cancer Treatment- Case in Point Cutaneous T-Cell Lymphoma

    Nov 1, 2011, 00:00

  • PRS7 Estudio De Costo-Efectividad De Beclometasona vs Ciclesonida Como Medicamentos Controladores En El Manejo Del asma En Pacientes Que asisten A Consulta Externa De NeumologÍa Pediátrica En El Hospital Universitario Clínica San Rafael De ...

    Nov 1, 2011, 00:00

  • PHP104 Identifying Factors Influencing Drug Reimbursement in Scotland

    Nov 1, 2011, 00:00

  • PMD79 An Evaluation of the Non-invasive Imaging Tests Used in Current Care of Tia and Minor ischemic Stroke in the Netherlands- How Much Practice Variation is There?

    Nov 1, 2011, 00:00

  • PCN171 Underlying Causes for Sub-Optimal Utilisation of Cancer Drugs Funds in England

    Nov 1, 2011, 00:00
  • «
  • 121
  • 122
  • 123 (current)
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »